Bladder cancer treatment co Vessi Medical raises $16.5m

Israeli urology medical device company Vessi Medical today announced the completion of a $16.5 million Series A financing round for its cryotherapy technology to treat non muscle invasive bladder cancer (NMIBC). The leading investors in the round are an undisclosed global strategic investor, ALIVE- Israel HealthTech Fund, Agriline, a trust of which UK investor Vincent Tchenguiz is a discretionary beneficiary, have joined founding investor The Trendlines Group.


Vincent Tchenguiz sees collapse of status-quo

Vessi’s minimally invasive solution for NMIBC provides a new therapeutic alternative to transurethral resection of bladder tumor (TURBT), the costly leading invasive surgical first-line therapy. NMIBC is defined as a cancer on the surface of the inner lining of the bladder. The company’s bladder-specific proprietary cryotherapy has the potential for significantly improving quality of life and the technology has been successfully used in a first in human study.

Vessi Medical founder & CEO Eyal Kochavi said,, “The participation of a global strategic investor in this round is a huge show of confidence in Vessi’s achievements and potential. The financing led by ALIVE will support expanding Vessi’s R&D capabilities, clinical studies in Israel and the US, and regulatory clearance, enabling us to achieve our goal of bringing Vessi’s treatment for NMIBC to patients and physicians to reduce side effects, improve patient outcomes, and lower health care costs.”

Vincent Tchenguiz, owner of Consensus Business Group and Agriline discretionary beneficiary said, “Positioned at the vanguard of technological advancement, Vessi Medical’s cutting-edge cryotherapy for NMIBC heralds a transformative shift in both cancer care and health economics. Our investment is a testament to our confidence in Vessi’s revolutionary potential to not only enhance patient outcomes but also to redefine care standards, alleviate suffering, and spearhead the development of more compassionate and efficacious treatment modalities.”

Published by Globes, Israel business news – – on February 14, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

The post Bladder cancer treatment co Vessi Medical raises $16.5m first appeared on


Shraga Brosh handed 14-month sentence for tax evasion |

Read More | The former Manufacturers Association of Israel president was convicted of evading taxes worth NIS 1.5 million and forging a document that was submitted to the Tax Authority. Former Manufacturers Association of Israel president Shraga Brosh has been handed a 14-month prison sentence following his conviction for tax evasion and fraud last July. […]

Upload ID page on for desktop

Australia’s manufacturing PMI rises in January, Red Sea disruptions impacted supply |

Read More | rarrarorro The Judo Bank Australia Manufacturing PMI was 50.1 in January, up from 47.6 in December. It snapped the tenth month of contraction in manufacturing sector conditions, supported by easing declines in new orders, production, and job shedding. Manufacturing output declined at a slower rate, driven by softer economic conditions and reduced […]